Virus genome sequence variants that appear over the course of an outbreak can be exploited to map the trajectory of the virus from one susceptible host to another. While such …
S Yu, X Zheng, B Zhou, J Li, M Chen… - Proceedings of the …, 2022 - National Acad Sciences
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has resulted in tremendous loss worldwide. Although viral spike (S) …
Abstract Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The spike (S) protein that mediates SARS-CoV-2 …
SARS-CoV-2 spike (S) glycoprotein is the key target of current vaccine development efforts to combat COVID-19; neutralizing antibodies bind S and interfere with S binding to its …
The emergence of SARS-CoV-2 has resulted in> 90,000 infections and> 3,000 deaths. Coronavirus spike (S) glycoproteins promote entry into cells and are the main target of …
The spike protein (S-protein) of SARS-CoV-2, the protein that enables the virus to infect human cells, is the basis for many vaccines and a hotspot of concerning virus evolution …
J Ogawa, W Zhu, N Tonnu, O Singer, T Hunter… - BioRxiv, 2020 - ncbi.nlm.nih.gov
The SARS-CoV2 coronavirus responsible for the current COVID19 pandemic has been reported to have a relatively low mutation rate. Nevertheless, a few prevalent variants have …
SARS-CoV-2 variants with spike (S)-protein D614G mutations now predominate globally. We therefore compare the properties of the mutated S protein (SG614) with the original …
B Zhou, TTN Thao, D Hoffmann, A Taddeo, N Ebert… - BioRxiv, 2020 - ncbi.nlm.nih.gov
During the evolution of SARS-CoV-2 in humans a D614G substitution in the spike (S) protein emerged and became the predominant circulating variant (S-614G) of the COVID-19 …